Preventing E-cadherin aberrant N -glycosylation at Asn-554 improves its critical function in gastric cancer
E-cadherin is a central molecule in the process of gastric carcinogenesis and its posttranslational modifications by N-glycosylation have been described to induce a deleterious effect on cell adhesion associated with tumor cell invasion. However, the role that site-specific glycosylation of E-cadher...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2016
|
| In: |
Oncogene
Year: 2015, Volume: 35, Issue: 13, Pages: 1619-1631 |
| ISSN: | 1476-5594 |
| DOI: | 10.1038/onc.2015.225 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/onc.2015.225 Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/onc2015225 |
| Author Notes: | S. Carvalho, T.A. Catarino, A.M. Dias, M. Kato, A. Almeida, B. Hessling, J. Figueiredo, F. Gärtner, J.M. Sanches, T. Ruppert, E. Miyoshi, M. Pierce, F. Carneiro, D. Kolarich, R. Seruca, Y. Yamaguchi, N. Taniguchi, C.A. Reis and S.S. Pinho |
| Summary: | E-cadherin is a central molecule in the process of gastric carcinogenesis and its posttranslational modifications by N-glycosylation have been described to induce a deleterious effect on cell adhesion associated with tumor cell invasion. However, the role that site-specific glycosylation of E-cadherin has in its defective function in gastric cancer cells needs to be determined. Using transgenic mice models and human clinical samples, we demonstrated that N-acetylglucosaminyltransferase V (GnT-V)-mediated glycosylation causes an abnormal pattern of E-cadherin expression in the gastric mucosa. In vitro models further indicated that, among the four potential N-glycosylation sites of E-cadherin, Asn-554 is the key site that is selectively modified with β1,6 GlcNAc-branched N-glycans catalyzed by GnT-V. This aberrant glycan modification on this specific asparagine site of E-cadherin was demonstrated to affect its critical functions in gastric cancer cells by affecting E-cadherin cellular localization, cis-dimer formation, molecular assembly and stability of the adherens junctions and cell-cell aggregation, which was further observed in human gastric carcinomas. Interestingly, manipulating this site-specific glycosylation, by preventing Asn-554 from receiving the deleterious branched structures, either by a mutation or by silencing GnT-V, resulted in a protective effect on E-cadherin, precluding its functional dysregulation and contributing to tumor suppression. |
|---|---|
| Item Description: | Published 20 July 2015 Gesehen am 29.04.2020 |
| Physical Description: | Online Resource |
| ISSN: | 1476-5594 |
| DOI: | 10.1038/onc.2015.225 |